These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 23540839

  • 1. Small molecule regulation of protein conformation by binding in the Flap of HIV protease.
    Tiefenbrunn T, Forli S, Baksh MM, Chang MW, Happer M, Lin YC, Perryman AL, Rhee JK, Torbett BE, Olson AJ, Elder JH, Finn MG, Stout CD.
    ACS Chem Biol; 2013; 8(6):1223-31. PubMed ID: 23540839
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease.
    Li D, Liu MS, Ji B, Hwang KC, Huang Y.
    Chem Biol Drug Des; 2012 Sep; 80(3):440-54. PubMed ID: 22621379
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation.
    Liu F, Kovalevsky AY, Louis JM, Boross PI, Wang YF, Harrison RW, Weber IT.
    J Mol Biol; 2006 May 19; 358(5):1191-9. PubMed ID: 16569415
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds.
    Yedidi RS, Liu Z, Wang Y, Brunzelle JS, Kovari IA, Woster PM, Kovari LC, Gupta D.
    Biochem Biophys Res Commun; 2012 May 11; 421(3):413-7. PubMed ID: 22469467
    [Abstract] [Full Text] [Related]

  • 15. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study.
    Maphumulo SI, Halder AK, Govender T, Maseko S, Maguire GEM, Honarparvar B, Kruger HG.
    Chem Biol Drug Des; 2018 Nov 11; 92(5):1899-1913. PubMed ID: 30003668
    [Abstract] [Full Text] [Related]

  • 16. Contrasting the effect of hinge region insertions and non-active site mutations on HIV protease-inhibitor interactions: Insights from altered flap dynamics.
    Mokhantso T, Sherry D, Worth R, Pandian R, Achilonu I, Sayed Y.
    J Mol Graph Model; 2024 Dec 11; 133():108850. PubMed ID: 39226791
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance.
    Naicker P, Achilonu I, Fanucchi S, Fernandes M, Ibrahim MA, Dirr HW, Soliman ME, Sayed Y.
    J Biomol Struct Dyn; 2013 Dec 11; 31(12):1370-80. PubMed ID: 23140382
    [Abstract] [Full Text] [Related]

  • 19. Computational analysis of HIV-1 protease protein binding pockets.
    Ko GM, Reddy AS, Kumar S, Bailey BA, Garg R.
    J Chem Inf Model; 2010 Oct 25; 50(10):1759-71. PubMed ID: 20925403
    [Abstract] [Full Text] [Related]

  • 20. Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters.
    Shen CH, Wang YF, Kovalevsky AY, Harrison RW, Weber IT.
    FEBS J; 2010 Sep 25; 277(18):3699-714. PubMed ID: 20695887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.